Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

How should continental vaccine manufacturers handle complex dynamics of supply and demand? ANALYSIS | The African Union has ...

A high bilirubin level, or hyperbilirubinemia ... Certain protease inhibitors used to treat human immunodeficiency virus (HIV) and targeted therapies like Nexavar (sorafenib), used to treat liver and ...

Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s ...

But scientists say it’s impossible to fight HIV without acknowledging people in the demographic groups that disproportionately contract the virus and are less likely than cisgender White men to ...

The low-cost test developed by Professor Vinayak Dravid and research professor Gajendra Shekhawat builds on an existing ...

Professor Thumbi Ndung'u and his team at the Africa Health Research Institute are pioneering a study that explores innovative ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

Neuroscientists have observed for the first time how structures deep in the brain are activated when the brain becomes aware of its own thoughts, known as conscious perception 1. The brain is ...

A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million HIV-negative people in the country use the jab every year over the next eight ...